Korea Today.zip Nov 5: KOSPI Plunges 5% and Triggers a Sell-Side Sidecar
South Korean stocks had a sharp sell-off on Thursday, November 5. The KOSPI closed at 5,383.80, down 5.28%, and the KOSDAQ fell 5.11% to 678.41. Sell-side sidecars were triggered on both markets during the session. The same day brought news from Hanwha Aerospace, Samsung Biologics and Kakao.
KOSPI: a 5% drop and a sidecar
The KOSPI lost 300.00 points to close at 5,383.80. A day earlier it had finished at 5,683.80 after swinging by more than 400 points, and it gave up that gain and ended below the November 3 close. Compared with the November 3 close of 5,648.79 the index is 4.69% lower, and against the October 29 close of 5,937.66 it is down about 9.3%.
Many market commentators tie the drop to the US midterm elections. Democrats won both the House and the Senate, and investors worried that a Democratic Congress and several newly elected governors could tighten rules on AI data centers. One report said 34 of the 36 governor candidates who won or led in their races back at least one data center restriction. Korea's market has a heavy weighting in AI chipmakers such as Samsung Electronics and SK hynix, which helps explain why the reaction was larger than elsewhere. This is a market interpretation and not a confirmed single cause.
A sell-side sidecar is a circuit breaker for program trading. It suspends program sell orders for five minutes when KOSPI 200 futures stay down at least 5% for at least one minute.
KOSDAQ: first sidecar since October 15
The KOSDAQ closed at 678.41, down 36.54 points. Its sell-side sidecar needs KOSDAQ 150 futures to fall at least 6% and the KOSDAQ 150 index to fall at least 3% at the same time for at least one minute, and this was the first one since October 15. Semiconductor equipment makers led the declines. With both markets hit on the same day, the move looked like broad risk reduction rather than a problem in one sector.
Hanwha Aerospace breaks ground in Poland
Hanwha Aerospace held a groundbreaking ceremony on November 4, local time, for a guided missile plant in Gorzow Wielkopolski, Poland, and announced it on November 5. The plant will produce the CGR-080, an 80 km class missile for the Polish version of the Chunmoo launcher known as Homar-K. It is the company's first guided missile production site abroad. The plant follows a supply contract worth about 5.6 trillion won signed with Poland's Armament Agency last December. Completion is targeted for 2028, first production for late 2029 and mass production from 2030. Hanwha Aerospace shares closed down 7.48% at 680,000 won. The logo shown is the Hanwha Group logo.
Samsung Biologics wins 97.98% in its tender offer
Samsung Biologics said 32,350,302 shares, or 97.98% of the target shares, were tendered in its offer for PolyPeptide Group, a global contract developer and manufacturer of peptides. That clears both the 66.7% minimum needed for the deal and the 90% level that allows the buyer to squeeze out the remaining holders. The agreed price is 1.46 billion Swiss francs, about 2.37 trillion won. Peptides are a core ingredient of GLP-1 obesity and diabetes drugs, so the deal extends Samsung Biologics beyond antibodies, mRNA and antibody-drug conjugates. Payment is due within 10 trading days after regulatory approvals in Europe, India, Australia and Brazil. Its shares closed up 1.67%.
Kakao pushes back its spin-off by a month
Kakao moved the effective date of its personnel-based spin-off from January 1 to February 1 of next year. It said the relisting review needs more time, so it shifted the main dates by about a month. The extraordinary shareholders meeting is set for January 15 and relisting for February 25. The absorption of Kakao Investment also moves to February 1. Kakao shares closed up 10.65% at 32,200 won, and its third-quarter results and a share cancellation decision came out the same day.
What to watch next
When an index falls this hard, company news can still move stocks in the opposite direction, as the gains at Samsung Biologics and Kakao showed. Next, watch whether another sidecar appears, how the discussion on US AI data center rules develops, and whether Kakao confirms its new timetable.
Sources: Korea Exchange, Hanwha Aerospace, Samsung Biologics, Kakao








Comments
Post a Comment